Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2021
October 29, 2021 at 06:28 pm
Entheon Biomedical Corp. reported earnings results for the third quarter and nine months ended August 31, 2021. For the third quarter, the company reported sales was CAD 0.005899 million. Net loss was CAD 1.72 million compared to CAD 0.350663 million a year ago. Basic loss per share from continuing operations was CAD 0.03. Diluted loss per share from continuing operations was CAD 0.03.
For the nine months, sales was CAD 0.007356 million. Net loss was CAD 7.02 million compared to CAD 1.09 million a year ago. Basic loss per share from continuing operations was CAD 0.13.